News | What’s happening at Epidauros
Apr 27, 2006
New Chief Executive
EPIDAUROS Biotechnologie AG has appointed Dr. Michael Lutz as new Chief Executive Officer [more]
Mar 16, 2006
License to Tm Bioscience Corporation
Tm Bioscience Licenses Key P450 Pharmacogenetic Marker from EPIDAUROS Biotechnologie AG [more]
Nov 03, 2004
License to Roche Molecular Systems, Inc.
EPIDAUROS Biotechnologie AG, Bernried, Germany, grants commercial license to important polymorphism of drug metabolism gene to Roche Molecular Systems, Inc. [more]
Apr 22, 2004
Break even in 2003
EPIDAUROS Biotechnologie AG has reached break even in 2003 for the first time since the foundation of the company in 1997. [more]
Jul 23, 2003
License from LGC Ltd. (UK)
EPIDAUROS Biotechnologie AG has licensed in gene variant from LGC Ltd. (UK) [more]
Displaying results 11 to 15 out of 15